ANTON GUETH
CIK 1274940 · last filed 2022-05-26
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$10.84M
Companies
4
Total Filings
34
Lifetime Open-Market Net
-$1.05M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ANTARES PHARMA, INC. (ATRS) Delisted | Director | 467,577 | $5.59 | $2.61M | -$808.0K | 18 | 2021-07-09 |
| NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB) Delisted | Director | 38,918 | $0.00 | $4 | $0 | 2 | 2016-01-08 |
| SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted | Director | 11,000 | $1.03 | $11.3K | $0 | 2 | 2012-12-21 |
| AIS | Director | 141,101 | $76.82 | $10.84M | -$237.6K | 11 | 2012-05-31 |
Recent Filings · Page 4 of 4
34 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2009-11-13 | AIS | Grant (A) | — | $0 | EDGAR |
| 2009-05-18 | AIS | Mixed | +1,000 | $600 | EDGAR |
| 2008-05-16 | AIS | Grant (A) | — | $0 | EDGAR |
| 2007-05-14 | AIS | Grant (A) | — | $0 | EDGAR |
Showing 31–34 of 34
Prev
Page 4 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.